Helicobacter pylori Infection.
Antibiotic resistance
Diagnosis
Gastric cancer
Helicobacter pylori
Microbial pathogenesis
Peptic ulcer
Journal
Gastroenterology clinics of North America
ISSN: 1558-1942
Titre abrégé: Gastroenterol Clin North Am
Pays: United States
ID NLM: 8706257
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
entrez:
24
5
2021
pubmed:
25
5
2021
medline:
26
10
2021
Statut:
ppublish
Résumé
Helicobacter pylori infection remains one of the most prevalent infections worldwide, causing significant morbidity and mortality from gastric malignancies and peptic ulcers. This article provides a summary of the microbiology and pathogenesis of this bacterium, emphasizing the complex and protean effects of H pylori on gastric epithelial cells, including stem and progenitor populations, and evasion of host immune defenses. Increasing antibiotic resistance has made management more challenging. This article discusses the appropriate diagnostic modality for different clinical scenarios, and the evolving treatment of H pylori infections, including the use of antibiotic susceptibility testing to aid regimen selection.
Identifiants
pubmed: 34024441
pii: S0889-8553(21)00013-3
doi: 10.1016/j.gtc.2021.02.001
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
261-282Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure S.F. Moss has served on the advisory boards of Redhill Biopharma and Phathom Pharmaceuticals, performs research sponsored by American Molecular Labs, and is a consultant to Takeda. The other authors have nothing to disclose.